vimarsana.com
Home
Live Updates
Nadofaragene Firadenovec Demonstrates Durable 5-Year Activity in NMIBC : vimarsana.com
Nadofaragene Firadenovec Demonstrates Durable 5-Year Activity in NMIBC
Nadofaragene firadenovec led to durable antitumor activity in BCG-unresponsive NMIBC either with CIS or papillary disease, according to 5-year data from the phase 3 Study CS-003.
Related Keywords
United States ,
American ,
Vikram Narayan ,
American Urological Association Annual Meeting ,
Ferring Pharmaceuticals ,
Urological Association Annual ,
Urological Oncology ,
Grady Memorial Hospital ,
Emory University School ,
Winship Cancer ,
Bacillus Calmette Gu ,
News ,
Conference ,
Urothelial Cancer ,
vimarsana.com © 2020. All Rights Reserved.